About

May 18-19, 2022    Paris, France

2nd International Conference on

Drug Safety and Pharmacovigilance

Longdom Conferences provide the platform to speakers and offer delegates the opportunity to share their ideas and network. We are pleased to welcome you to attend and associate with us at 2nd International Conference on Drug Safety and Pharmacovigilance on May 18-19, 2022 in Paris, France

Drug Safety 2022 mainly focuses on the theme “International Conference on Pharmaceutics and Drug Safety”. Guided by a line-up of expert speakers, researchers, doctors, students, professors and all the interested people in Pharmaceutics & Drug Safety  from all over the world for our Drug Safety 2022 to ensure that public receives the best possible care and can look forward to a bright future.

Drug safety 2022, foresee over 200 participants from 7 continents with revolutionary subjects, discussions, and expositions. This will be excellent viability for the researchers, students and the delegates from Universities and Institutes to intermingle with the world-class scientists, speakers, technicians, technical practitioners and industry professionals working in the field of pharmaceutics and drug safety.

Scientific Sessions:

  1. Pre-clinical and clinical trails
  2. Adverse drug reactions
  3. Good Pharmacovigilance practice
  4. Drug Safety
  5. Quality assurance
  6. Prevalence of Potential Drugs
  7. Pharmaceutical sciences

Track1  Pre-clinical and clinical trails

Clinical trials allow drug testing for safety assessment in different population. preclinical development referred as preclinical studies or nonclinical Studies, is a research stage carried at initial level of increasing accessibility and iterative testing and drug safety data are collected. Main goals of preclinical studies to determine the safe dose in first phase and evaluate the product safety profile. Product may include drugs, gene safety, and diagnostic tools.

Relevant Conferences: Pharmaceutics Conferences | Drug Safety Conferences | Pharmaceutics Meetings | International Conferences | Medical Meetings | Pharmaceutics and Drug Discovery Conferences | International Drug safety Conferences | International Pharmaceutics Conferences

Track 2- Adverse drug reactions

Adverse drug reaction is a form of toxicity or increase drug effect which mainly occurs during efficient use. In US 3-7% hospitalization are due to ADRs. ADRs occur during 10-20% of hospitalizations, 10-20% of ADRs are severe. ADR’s showed no pharmacokinetic effects resulting in 0% death incidence till date. suggested rate of 0.5 – 0.9% may be high because patient have some serious disorder. Severity and incidence vary through patients characteristic and through drug factors.

Relevant Conferences: Pharmaceutics Conferences | Drug Safety Conferences | Pharmaceutics Meetings | International Conferences | Medical Meetings | Pharmaceutics and Drug Discovery Conferences | International Drug safety Conferences | International Pharmaceutics Conferences

Track 3- Pharmacovigilance practice

 Pharmacovigilance practice and pharmacoepidemiology in risk management to increase the possibility of beneficial effects of drug and adverse effects in population maintain reporting practice to avoiding the major problems in risk management. Also concentrate to examine information by collecting drug effects, caused by medicine. pharmacovigilance and clinical trial services should have pharmacovigilance certification.

Relevant Conferences: Pharmaceutics Conferences | Drug Safety Conferences | Pharmaceutics Meetings | International Conferences | Medical Meetings | Pharmaceutics and Drug Discovery Conferences | International Drug safety Conferences | International Pharmaceutics Conferences

Track1- Drug Safety

Statistics is playing an important role in clinical research in regulatory submission. Adverse drug reactions report can also be considered for the regulatory submission. pharmacovigilance process is achieved by ICH guidelines.

Relevant Conferences: Pharmaceutics Conferences | Drug Safety Conferences | Pharmaceutics Meetings | International Conferences | Medical Meetings | Pharmaceutics and Drug Discovery Conferences | International Drug safety Conferences | International Pharmaceutics Conferences

Track 5 Quality assurance

Quality assurance is a process by which we can prevent the mistakes and defects in manufactured product. So that, when we are delivering the product customers does not face any problem.

Relevant Conferences: Pharmaceutics Conferences | Drug Safety Conferences | Pharmaceutics Meetings | International Conferences | Medical Meetings | Pharmaceutics and Drug Discovery Conferences | International Drug safety Conferences | International Pharmaceutics Conferences

Track 6- Prevalence of Potential Drugs

The main purpose of this study is to evaluate the prevalence and explain the characteristics of PDDIs  in medical recommendation of hospitalized surgical patients. In this transverse study, we examine 370 medical prescriptions from the surgery unit of a Mexican public teaching hospital. The classification and identification of potential drug-drug interactions were performed with the Micromedex 2.0 electronic drug information database. Results were examined with illustrative statistics and we estimated OR (odds ratio) to determine associated risk factors.

Relevant Conferences: Pharmaceutics Conferences | Drug Safety Conferences | Pharmaceutics Meetings | International Conferences | Medical Meetings | Pharmaceutics and Drug Discovery Conferences | International Drug safety Conferences | International Pharmaceutics Conferences

Track 7- Pharmaceutical sciences

The pharmaceutical science is an extortionate scope of logical controls of revelation and advancement of newly developed medications and treatments. Pharmaceutical sciences includes the basic fundamental standards of physical and compound science, designing, organic chemistry, and science to see how to upgrade transference of medications to the body and make an interpretation of this coordinated comprehension into as good as ever treatments against human ailment.

Relevant Conferences: Pharmaceutics Conferences | Drug Safety Conferences | Pharmaceutics Meetings | International Conferences | Medical Meetings | Pharmaceutics and Drug Discovery Conferences | International Drug safety Conferences | International Pharmaceutics Conferences

Market analysis

The international pharmaceutics and drug safety software market is assured to grow at a compound annual growth rate of 6.5% during 2014-2019, expected to achieve a value of $154.1 Million in 2019. As of 2014, North America bears the highest share of international Pharmacovigilance and drug safety software market, followed by Europe. Although, Asian and Latin American countries shows highest growth market, rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations

  1. Updates
  2. Solutions
  3. Training
  4. Surveillance
  5. Services & Software’s
  6. Reporting & Monitoring

International pharmaceuticals market was structured at $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to the report of current Pharma market research by The Business Research CompanySpeed up growth compared to 5.2% for the years before 2017 but slower than other two large healthcare segments, medical equipment, and healthcare services. Healthcare is growing at over 7% per year.

 Past Conference Reports:

Euro Pharma 2020 

We gratefully thank all our wonderful  speakers and delegates for making the Euro Pharma 2020 webinar successful. International Webinaron Pharmaceutics and Drug Discovery, hosted by the Longdom Conference was held during June 15, 2020 at GMT+1  based on the theme “Innovations and Advancements in Pharmaceutics and Drug Discovery "

The webinar was initiated with the honourable presence of the keynote forum. The list includes:

  1. Souvik Basak, Dr. B. C Roy College of Pharmacy, India
  2. Joshua A Eldridge ,  University of Kentucky , USA
  3. Prachi V Atre,  St.John’s University, USA
  4. Yasmine Gabal ,  University of Kentucky , USA
  5. Ajit Narang, Genentech, Inc. San Francisco Bay Area USA

Pharmaceutics 2021

We gratefully thank all our wonderful  speakers and delegates for making the Pharmaceutics 2021 webinar successful. International Webinar on Pharmaceutics and Drug Discovery, hosted by the Longdom Conference was held during February 28, 2021 at GMT+1  based on the theme “Innovations and Advancements in Pharmaceutics and Drug Discovery "

The webinar was initiated with the honourable presence of the keynote forum. The list includes:

  1. Maulik Patel, Pharmaceutical Formulation R&D Professional, China
  2. Shajila Siricilla, Vanderbilt University USA
  3. Muhammad Sibte Hasan Mahmood, Grand River Hospital, Canada
  4. Mallesh Kurakula ,  University of Memphis , USA
  5. Foziyah Zakir, Delhi Pharmaceutical Sciences and Research University, India

Pharma 2021

We gratefully thank all our wonderful  speakers and delegates for making the Pharma 2021 webinar successful. Webinar on Pharmaceutics and Drug Discovery, hosted by the Longdom Conference was held during May 31, 2021  at GMT+1 based on the theme “Innovations and Advancements in Pharmaceutics and Drug Discovery "

The webinar was initiated with the honourable presence of the keynote forum. The list includes:

  1. Pradeep Deshmukh, Pacific Toxicology Consulting, Pune, India
  2. Iris Valtingojer  Molecular Oncology Research Department , France
  3. Muhammad Sibte Hasan Mahmood, Grand River Hospital, Canada
  4. Souvik Basak, Dr. B. C Roy College of Pharmacy, India
  5. Foziyah zakir, Delhi Pharmaceutical Sciences and Research University, India

For More details visit: https://www.longdom.com/drugsafety

Drug Discovery 2020

We gratefully thank all our wonderful  speakers and delegates for making the Drug Discovery 2020 webinar successful. “Webinar on Drug Discovery”, hosted by the Longdom Conferences was held during April 30, 2020 at London, UK based on the theme “Current and Future Trends in Drug Discovery"

The webinar was initiated with the honourable presence of the keynote forum. The list includes:

  1. Amrik Basran, Avacta Lifesciences. United Kingdom
  2. Madhu Gupta , Delhi Pharmaceutical Sciences & Research University, India       
  3. AliciaWu Mingshu, Guangzhou Medical Cancer Centre,  China
  4. Rashid Mahmood, SURGE Laboratories Private Limited,Pakistan.
  5. Wayne J. M. Karim, Yokohama-city University, Japan

For More details visit: https://www.longdom.com/drugsafety

Pharmacology 2020

We gratefully thank all our wonderful  speakers and delegates for making thePharmacology 2020 webinar successful.\ “Webinar on  Pharmacology”, hosted by the Longdom Conferences was held during May 31, 2020 at London, UK based on the theme “Innovations And Advancements in Pharmaceutics"

The webinar was initiated with the honourable presence of the keynote forum. The list includes:

  1. Wasfi Alazzam, Avacta Lifesciences. United Kingdom
  2. Anwar  Khan ,Luton & Dunstable University Hospital, Luton UK
  3. Foziyah Zakir, Delhi Pharmaceutical Sciences and Research University (DPSRU), India
  4. Rashid Mahmood, Surge Laboratories Private Limited,Pakistan.
  5. Wayne J. M. Karim, Yokohama-city University, Japan

With the grand success of Pharmaceutics 2021, Longdom Conferences  is proud to announce the " 2nd International Conference Pharmaceutics and Drug safety" to be held March 23-24, 2022 at Berlin, Germany

For More details visit: https://www.longdom.com/drugsafety

  [email protected]
  [email protected]
  [email protected]
Speakers Interview